ARTERRA BIOSCIENCE
Milan Stock Exchange ARBS.MI
ARTERRA BIOSCIENCE Total Non-Current Liabilities for the year ending December 31, 2023: USD 1.06 M
ARTERRA BIOSCIENCE Total Non-Current Liabilities is USD 1.06 M for the year ending December 31, 2023, a -19.24% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
-
ARTERRA BIOSCIENCE Total Non-Current Liabilities for the year ending December 31, 2022 was USD 1.31 M, a -18.19% change year over year.
-
ARTERRA BIOSCIENCE Total Non-Current Liabilities for the year ending December 31, 2021 was USD 1.60 M, a -13.47% change year over year.
-
ARTERRA BIOSCIENCE Total Non-Current Liabilities for the year ending December 31, 2020 was USD 1.85 M, a 27.42% change year over year.
-
ARTERRA BIOSCIENCE Total Non-Current Liabilities for the year ending December 31, 2019 was USD 1.45 M, a -8.30% change year over year.
Key data
| Date | Total Non-Current Liabilities | Shareholders' Equity | Other Liabilities | Total Liabilities |
|---|
Market news
Loading...
Milan Stock Exchange: ARBS.MI
| CEO | Ms. Maria Gabriella Colucci |
| IPO Date | Oct. 28, 2019 |
| Location | Italy |
| Headquarters | via Benedetto Brin, 69 Napoli, 80142Italy |
| Employees | 34 |
| Sector | Health Care |
| Industries | |
Description
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. It develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Naples, Italy.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email